India Neomycin Market To grow at a formidable rate during the Forecast Period
High prevalence of ear and ocular infections is expected to drive the growth of India neomycin market during the forecast period
According to TechSci Research report, “India Neomycin Market By Form (Tablet, Eye and Ear Drops, Ointment, Syrup and Injection), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral, Ophthalmic, Otic, Topical and Intravenous), By Type of Composition (Neomycin sulphate v/s neomycin palmitate), By Distribution Channel (Online v/s Offline), By Application (Ear Infection, Skin Infection, Ocular Infection and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026”, the Indianeomycin market is expected to grow at a formidable rate during the forecast period. Oral neomycin is used in infections that are suspected to be caused by susceptible bacteria in order tolessen the risk associated with development of drug-resistant bacteria.The drug is further used to decrease the risk of infection after certain intestinal surgeries. This in turn is expected to fuel the market growth through FY2026. In addition to this, application of this class of drug for defense against infection resistance is further estimated to positively influence the market growth in the years to come. However, side-effects associated with drug consumption such as nausea, vomiting, and diarrhea can restrict the market growth over the next few years.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on"IndiaNeomycin Market"
The Indianeomycin market is segmented based on form, source, route of administration, type of composition, distribution channel, application, end user, company, and region.In terms of distribution channel, the market is split into online and offline. The offline channel is expected to dominate the market over the coming yearsas it is more suitable for the consumers to buy medicines from a pharmacy in the vicinity. Based on application, the market can be fragmented into ear infection, skin infection, ocular infection and others. The ear infection segment is expected to register high CAGR in the market over the coming years on account of rising prevalence of skin infections among the population. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. The in-house segment dominated the market until FY2020 because keeping manufacturing in-house provides a lot of flexibility to change the product. Contract manufacturing organizations segment is expected to witness significant growth in the market on account of high scalability of products coupled with substantial growth in number of contract manufacturers in the country.
Taj Pharmaceuticals Ltd., Salvavidas Pharmaceutical Pvt. Ltd., Lexicare Pharma Pvt. Ltd., Facemed Pharmaceuticals Pvt. Ltd., Unichem Laboratories Ltd., Gujarat Pharma Lab Pvt. Ltd., Dupen Lab Pvt. Ltd., Caldern Pharmaceuticals Ltd., Sunways India Pvt. Ltd., Allergan India Pvt.Ltd. and others are some of the leading players operating in India neomycin market. Companies operating in the market are using strategies such as product launches, mergers and acquisitions and research collaborations to boost their share and increase their geographic reach.
“India neomycin market is expected to witness high growth during the forecast period as the neomycin sulfate preparation is highly recommended asan adjunctive therapy in hepatic coma for the reduction of ammonia-forming bacteria in the intestinal tract. Also, the neomycinantibiotic isavailable in many topical medications such as creams, ointments, and eyedrops. This is further expected to create lucrative opportunities for the market growth of India neomycinmarket over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research basedIndia management consulting firm.
“IndiaNeomycin MarketBy Form (Tablet, Eye and Ear Drops, Ointment, Syrup and Injection), By Source (In-house v/s Contract Manufacturing Organizations), By Route of Administration (Oral, Ophthalmic, Otic, Topical and Intravenous), By Type of Composition (Neomycin sulphate v/s neomycin palmitate), By Distribution Channel (Online v/s Offline), By Application (Ear Infection, Skin Infection, Ocular Infection and Others), By End User (Adult v/s Paediatric), By Company, By Region, Forecast & Opportunities, FY2026”, has evaluated the future growth potential of India neomycin market and provides statistics &information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in India neomycin market.